- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02680210
Self-defining Memories in Patients With a TBI (IDENTITY)
May 9, 2019 updated by: AZOUVI, Centre d'Investigation Clinique et Technologique 805
Self-defining Memories in Patients With a TBI and Their Relationships With Cognitive, Emotional and Behavioural Dimensions
The study will be conducted over 18 months.
The main objective of this study is to explore the relationships between autobiographical memory and specific cognitive measures, as well as emotional and behavioural measures in patients who have suffered a moderate to severe TBI.
Secondary objectives are to assess the psychometric properties of a self-defining memories questionnaire and to characterize autobiographical memory in the TBI population.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
A total of 40 participants (20 non-consecutive adults with a moderate or severe TBI and 20 volunteers with any history of neurological or psychiatric disease) will be recruited into the study.
The duration of the protocol is 70 minutes.
As regards the assessment, three questionnaires will be administered in order to evaluate self-defining memories, apathetic manifestations and anxio-depressive symptoms.
In addition, four cognitive measures will be used to assess verbal episodic memory, working memory, cognitive flexibility and verbal fluency.
Study Type
Interventional
Enrollment (Actual)
32
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ile De France
-
Garches, Ile De France, France, 92380
- Hopital Raymond Poincare
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- patients with a moderate or severe TBI occurred at least 6 months ago (initial Glasgow Coma Scale score ≤ 12 or post-traumatic amnesia duration > 1 week)
- patients ≥ 18 years old and who have signed a letter of information
Exclusion Criteria:
- history of neurological and/or psychiatric disease
- persistent motor, sensitive and instrumental disorders that could disturb the efficient evaluation of the participant
- patients who refused to participate in the study
- non affiliation to a social security scheme
- patients under guardianship or trusteeship
- pregnant woman
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: cognitive measures and questionnaires
the material of the study will consist of cognitive measures and questionnaires in order to (1) compare the cognitive performances and behavioral manifestations between patients with TBI and volunteers without neurological disorders and (2) to analyze the links between cognitive and behavioural measures in the TBI population
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
self-defining memory score
Time Frame: 20 minutes
|
self-defining memories will be measured using the self-defining memories questionnaire
|
20 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
verbal episodic memory score
Time Frame: 20 minutes
|
verbal episodic memory will be measured using the California Verbal Learning Test
|
20 minutes
|
|
working memory score
Time Frame: 10 minutes
|
working memory will be measured using verbal span task
|
10 minutes
|
|
cognitive flexibility score
Time Frame: 5 minutes
|
cognitive flexibility will be measured using the Trail Making Test
|
5 minutes
|
|
verbal fluency score
Time Frame: 5 minutes
|
verbal fluency will be measured using the verbal fluency task
|
5 minutes
|
|
apathy score
Time Frame: 5 minutes
|
apathetic manifestations will be measured using the Apathy Evaluation Scale
|
5 minutes
|
|
anxio-depressive score
Time Frame: 5 minutes
|
anxio-depressive symptoms will be measured using the Hospital Anxiety and Depression Scale
|
5 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Annabelle Arnould, psychologue, Hopital Raymond Poincare
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 4, 2016
Primary Completion (Actual)
May 1, 2016
Study Completion (Actual)
May 1, 2016
Study Registration Dates
First Submitted
January 29, 2016
First Submitted That Met QC Criteria
February 8, 2016
First Posted (Estimate)
February 11, 2016
Study Record Updates
Last Update Posted (Actual)
May 13, 2019
Last Update Submitted That Met QC Criteria
May 9, 2019
Last Verified
May 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Mental Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Neurologic Manifestations
- Wounds and Injuries
- Neurocognitive Disorders
- Craniocerebral Trauma
- Trauma, Nervous System
- Brain Injuries
- Brain Injuries, Traumatic
- Neurobehavioral Manifestations
- Cognition Disorders
- Memory Disorders
Other Study ID Numbers
- 2015-A00996-43
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neurobehavioral Manifestations
-
Columbia UniversityCompletedNeurologic Manifestations | Neurobehavioral ManifestationsUnited States
-
KU LeuvenResearch Foundation - Flanders (Fonds Wetenschappelijk Onderzoek)Not yet recruitingAnhedonia | Emotional Distress
-
Jiangsu Province Nanjing Brain HospitalRecruiting
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH); Duke UniversityCompletedAnhedoniaUnited States
-
University of New MexicoNational Institute of Mental Health (NIMH)Completed
-
University of OxfordCompleted
-
Mclean HospitalActive, not recruiting
-
University of FloridaNational Institute of Mental Health (NIMH)Completed
-
National Institute on Alcohol Abuse and Alcoholism...CompletedNeurobehavioral Manifestations | SleepUnited States
Clinical Trials on Questionnaires and cognitive measures
-
Assistance Publique Hopitaux De MarseilleTerminated
-
Maastricht University Medical CenterRecruiting
-
Canadian Forces Health Services Centre OttawaRecruiting
-
Maastricht UniversityAristotle University Of Thessaloniki; P1vital Products LTD.; Biotrial; University... and other collaboratorsCompletedDepression | Schizophrenia | Motivation | Anhedonia, Physical | Anhedonia, Social | Negative Symptoms With Primary Psychotic DisorderGermany, Greece, Netherlands, Spain
-
University of PennsylvaniaNational Institute on Aging (NIA)RecruitingParkinson Disease | Lewy Body Dementia With Behavioral Disturbance | Lewy Body Parkinson Disease | Parkinson Disease DementiaUnited States
-
Memorial Sloan Kettering Cancer CenterIcahn School of Medicine at Mount Sinai; Hackensack Meridian Health; Derald H...CompletedLeukemia | Multiple Myeloma | Non-Hodgkin's Lymphoma | Hodgkin's DiseaseUnited States
-
Wake Forest University Health SciencesCompleted
-
Azienda Unita Sanitaria Locale di PiacenzaCompletedHearing Loss, Age-RelatedItaly
-
Istituto Ortopedico RizzoliCompleted
-
Children's Hospital of PhiladelphiaLaerdal MedicalCompleted